ZYKADIA 150 mg/1
ceritinib · TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
ZYKADIA is a tablet, film coated containing ceritinib at 150 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- ZYKADIA
- Generic Name
- ceritinib
- NDC Code (Product)
0078-0694- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA211225
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 03/18/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is ZYKADIA used for?
ZYKADIA contains ceritinib. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is ZYKADIA a controlled substance?
ZYKADIA is not classified as a controlled substance by the DEA.
What is the generic name for ZYKADIA?
The generic name for ZYKADIA is ceritinib. There are no other listed brand versions of ceritinib.
What is the NDC code for ZYKADIA 150 mg/1?
The NDC (National Drug Code) for ZYKADIA 150 mg/1 is 0078-0694, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)